Product Description: AZP-531 is an analogue of unacylated ghrelin designed to improve glycaemic control and reduce weight.
Applications: Metabolism-sugar/lipid metabolism
Formula: C40H63N15O13
References: [1]Julien M, et al. In vitro and in vivo stability and pharmacokinetic profile of unacylated ghrelin (UAG) analogues. Eur J Pharm Sci. 2012 Nov 20;47(4):625-35./[2]Delhanty PJ, et al. Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucosehomeostasis. FASEB J. 2013 Apr;27(4):1690-700./[3]Allas S, et al. Safety, tolerability, pharmacokinetics and pharmacodynamics of AZP-531, a first-in-class analogue of unacylated ghrelin, in healthy and overweight/obese subjects and subjects with type 2 diabetes. Diabetes Obes Metab. 2016 Sep;18(9):868-74.
CAS Number: 1088543-62-7
Molecular Weight: 962.02
Compound Purity: 98.54
Research Area: Metabolic Disease; Endocrinology
Solubility: H2O : 100 mg/mL (ultrasonic)
Target: GHSR